Jazz Pharmaceuticals (JAZZ) cash on hand

Cash · fiscal 2025
$2.44B

Jazz Pharmaceuticals (JAZZ) held cash of $2.44B at the end of fiscal 2025 (December 31, 2025). That is 18.4% lower than the $2.99B of fiscal 2024. Figures as of 18 Nov 2026, 04:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$2.44B
Change on fiscal 2024
−18.4%
Highest on record
$2.99Bfiscal 2024
Lowest on record
$881.48Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Jazz Pharmaceuticals cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $2.99B in fiscal 2024 and the lowest $881.48M in fiscal 2022.

History · 4 fiscal years

Cash by fiscal year

Jazz Pharmaceuticals cash on hand, year by year

Jazz Pharmaceuticals (JAZZ) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$2.44B 18.4% down
2024$2.99B 84.0% up
2023$1.63B 84.5% up
2022$881.48M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

Cash at health care companies of similar size

Cash of Jazz Pharmaceuticals and comparable companies
CompanyCashFiscal year
Neurocrine Biosciences NBIX$1.48B2025
Ascendis Pharma ASND€616.04M2025
ICON ICLR$647.30M2025
Jazz Pharmaceuticals JAZZ$2.44B2025
Solventum SOLV$878.00M2025
BridgeBio Pharma BBIO$587.48M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on JAZZ

Jazz Pharmaceuticals, figure by figure

Jazz Pharmaceuticals (JAZZ) overview: price, valuation and scorecardAll health care companies by market value

Jazz Pharmaceuticals cash on hand: questions and answers

How much cash does Jazz Pharmaceuticals have?

Jazz Pharmaceuticals (JAZZ) held cash of $2.44B at the end of fiscal 2025 (December 31, 2025). That is 18.4% lower than the $2.99B of fiscal 2024.

What are the highest and lowest cash figures on record for Jazz Pharmaceuticals?

Across the 4 fiscal years on record (2022–2025), the highest was $2.99B in fiscal 2024 and the lowest $881.48M in fiscal 2022.

How is Jazz Pharmaceuticals's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Jazz Pharmaceuticals (JAZZ) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/JAZZ/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.